Maria de Los Angeles Ramirez

Maria de Los Angeles Ramirez

Auto-generated profile, based on publicly available information

Maria de Los Angeles Ramirez

Université de Strasbourg, CNRS, Institut de Physique et Chimie des Matériaux, UMR CNRS-UdS 7504, 23 Rue du Loess, BP 43, 67034 Strasbourg, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2018 in ACS Catalysis
Verified
Journal Article
Closed access
QWQi Wang
Qi Wang
FFFangyu Fu
Fangyu Fu
SYSha Yang
Sha Yang
MMMarta Martinez Moro
Marta Martinez Moro
MRMaria de Los Angeles Ramirez
Maria de Los Angeles Ramirez
DADidier Astruc
Didier Astruc

1 December 2019 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
DSDesirè Di Silvio
Desirè Di Silvio
MMMarta Martínez-Moro
Marta Martínez-Moro
CSCristian Salvador
Cristian Salvador
MRMaria de Los Angeles Ramirez
Maria de Los Angeles Ramirez
PCPaolin Rocio Cáceres-Vélez
Paolin Rocio Cáceres-Vélez
SMSergio Moya
Sergio Moya

7 December 2019 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
MBMaría Inés Diaz Bessone
María Inés Diaz Bessone
LGLorena Simón Gracia
Lorena Simón Gracia
PSPablo Scodeller
Pablo Scodeller
MRMaría de Los Angeles Ramirez
María de Los Angeles Ramirez
MHMaría Amparo Lago Huvelle
María Amparo Lago Huvelle
MSMarina Simian
Marina Simian
Background: Tamoxifen (Tam) is the most frequent treatment for estrogen receptor (ER) positive breast cancer. We recently showed that fibronectin (FN) leads to Tam resistance and selection of breast cancer stem cells. With the aim of developing a nanoformulation that would simultaneously tackle ER and FN/β1 integrin interactions, we designed polyethylene glycol-polycaprolactone polymersomes polymersomes (PS) that carry Tam and are functionalized with the tumor-penetrating iRGD peptide (iRGD-PS-Tam). Results: Polyethylene glycol-polycaprolactone PS were assembled and loaded with Tam using the hydration film method. The loading of encapsulated Tam, measured by UPLC, was 2.4 ± 0.5 mol Tam/mol polymer. Physicochemical characterization of the PS demonstrated that iRGD functionalization had no effect on morphology, and a minimal effect on the PS size and polydispersity (176 nm and Pdi 0.37 for iRGD-TAM-PS and 171 nm and Pdi 0.36 for TAM-PS). iRGD-PS-Tam were taken up by ER+ breast carcinoma cells in 2D-culture and exhibited increased penetration of 3D-spheroids. Treatment with iRGD-PS-Tam inhibited proliferation and sensitized cells cultured on FN to Tam. Mechanistically, treatment with iRGD-PS-Tam resulted in inhibition ER transcriptional activity as evaluated by a luciferase reporter assay. iRGD-PS-Tam reduced the number of cells with self-renewing capacity, a characteristic of breast cancer stem cells. In vivo, systemic iRGD-PS-Tam showed selective accumulation at the tumor site. Conclusions: Our study suggests iRGD-guided delivery of PS-Tam as a potential novel therapeutic strategy for the management of breast tumors that express high levels of FN. Future studies in pre-clinical in vivo models are warranted.

9 October 2019 in Langmuir
Verified
Journal Article
Closed access
VCVictor Ezequiel Cuenca
Victor Ezequiel Cuenca
HMHernan Martinelli
Hernan Martinelli
MRMaria de Los Angeles Ramirez
Maria de Los Angeles Ramirez
Hernán A. RitaccoHernán A. Ritacco
Hernán A. Ritacco
PAPatrizia Andreozzi
Patrizia Andreozzi
SMSergio Moya
Sergio Moya

30 January 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
BFBarbara Freis
Barbara Freis
MRMaría De Los Ángeles Ramírez
María De Los Ángeles Ramírez
SFSonia Furgiuele
Sonia Furgiuele
FJFabrice Journe
Fabrice Journe
CCClémence Cheignon
Clémence Cheignon
SBSylvie Bégin-Colin
Sylvie Bégin-Colin

27 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
CVCostanza Vanni
Costanza Vanni
ABAnne Bodlenner
Anne Bodlenner
MMMarco Marradi
Marco Marradi
JSJérémy P. Schneider
Jérémy P. Schneider
MRMaria de Los Angeles Ramirez
Maria de Los Angeles Ramirez
Camilla MatassiniCamilla Matassini
Camilla Matassini
Among carbohydrate-processing enzymes, Jack bean α-mannosidase (JBα-man) is the glycosidase with the best responsiveness to the multivalent presentation of iminosugar inhitopes. We report, in this work, the preparation of water dispersible gold nanoparticles simultaneously coated with the iminosugar deoxynojirimycin (DNJ) inhitope and simple monosaccharides (β-d-gluco- or α-d-mannosides). The display of DNJ at the gold surface has been modulated (i) by using an amphiphilic linker longer than the aliphatic chain used for the monosaccharides and (ii) by presenting the inhitope, not only in monomeric form, but also in a trimeric fashion through combination of a dendron approach with glyconanotechnology. The latter strategy resulted in a strong enhancement of the inhibitory activity towards JBα-man, with a Ki in the nanomolar range (Ki = 84 nM), i.e., more than three orders of magnitude higher than the monovalent reference compound.